EP 2 379 063 B1 relates to a pharmaceutical formulation comprising an erosion matrix.
Brief outline of the case
The petition for review, filed by Opponent 1, concerns the decision T 537/16, according to which the patent could be maintained on the basis of the proprietor’s AR1.